Dr Awa Coll Seck Global Subsidies
Nicole Nogoy: GigaScience...how licensing can change the way we do research
1 Pharmacometrics Impact on FDA Decisions & Recommendations: Past, Present & Future Bob Powell, PharmD Director (2/05-1/07), Pharmacometrics, OCP Office.
Susan’S Ten Commandments For Worm Control
InTech-Antitubercular Drugs Development Recent Advances in Selected Therapeutic Targets and Rational Drug Design
Counterfeit Drugs By: Amanda Benson. Explanation Counterfeit Drugs are when money is used to by ineffective drugs or ones that can severely harm someone.
Pharmacogenetics: From DNA to Drug Treatment Andrew Schork COGS 174 3/14/2012.
Insights from economic- epidemiology Ramanan Laxminarayan Resources for the Future, Washington DC.
Pharmaceutical Regulation: A Matter of Life and Death Sam Peltzman Booth School of Business University of Chicago.
Global ACT Subsidy Role of RBM Partnership Dr Awa Marie Coll-Seck Executive Director, RBM Partnership APPMG London July 2007.
Counterfeit Drugs
AccuDava, Inc. Personalized Molecular Cancer Diagnostics Saving lives, Reducing costs
